It has also been shown that the expression of KLK11 in breast cancer contributes significantly to the progression of cancer by increasing the bioavailability of IGF through degradation of IGFBP-3 [ 30 ] , and extremely significant expression of KLK11 was observed in patients with breast cancer grades I and II compared to III.
← all excerpts
Novel Biomarkers Aim at Detecting Metastatic Sentinel Lymph Nodes in Breast Cancer
1
—
—